Study on the Safety and Efficacy of a Time-of-Day-Based Individualized Tacrolimus Dosing Regimen in Kidney Transplant Recipients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 100 participants.

Also called NCT07877103

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07877103
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07877103. Randomized; no masking; primary purpose treatment. Start 2026-10-25 (anticipated); primary completion 2027-12-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study on the Safety and Efficacy of a Time-of-Day-Based Individualized Tacrolimus Dosing Regimen in Kidney Transplant Recipients
Condition
End-Stage Renal Disease
Intervention (Drug)
Chronotherapy-based individualized low-morning high-evening tacrolimus dosing
Intervention (Drug)
conventional dosing regimen
Lead sponsor
The First Affiliated Hospital of Guangzhou Medical University (class: other)
Collaborator
Second Affiliated Hospital of Guangzhou Medical University (class: other)
Collaborator
The Third Affiliated Hospital of Guangzhou Medical University (class: other)
Collaborator
Guangdong Provincial Hospital of Traditional Chinese Medicine (class: other)
Collaborator
Zhujiang Hospital (class: other)

Record details

Record id
cardio:ct-nct07877103
Content hash
8abc1bc17f48ef427794cb0bf25452b6d3d781c0815362855d54c10f0f59c4f4